During the past decade, Central Arkansas Veterans Healthcare System conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 23 clinical trials were completed, i.e. on average, 79.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 15 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Arkansas Veterans Healthcare System" #1 sponsor was "Centers for Disease Control and Prevention" with 12 trials, followed by "SWOG Cancer Research Network" with 11 trials sponsored, "Central Arkansas Veterans Healthcare System" with 5 trials sponsored, "AstraZeneca" with 3 trials sponsored and "US Department of Veterans Affairs" with 3 trials sponsored. Other sponsors include 46 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Arkansas Veterans Healthcare System" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "US Department of Veterans Affairs" with 10 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "Central Arkansas Veterans Healthcare System" with 2 trials as a collaborator. Other collaborators include 49 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "Central Arkansas Veterans Healthcare System" are "Tuberculosis" (10 trials), "Critical Limb Ischemia" (4 trials), "HIV Infections" (4 trials), "Peripheral Vascular Disease" (4 trials) and "Prostate Cancer" (4 trials). Many other conditions were trialed in "Central Arkansas Veterans Healthcare System" in a lesser frequency.

Most popular intervention types in "Central Arkansas Veterans Healthcare System" are "Drug" (48 trials), "Device" (13 trials), "Biological" (12 trials), "Other" (12 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Rifabutin" (4 trials), "AC2993" (3 trials), "Isoniazid" (3 trials) and "paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Central Arkansas Veterans Healthcare System" are 76 trials for "All" genders, 7 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Central Arkansas Veterans Healthcare System". 1 are not yet recruiting, 9 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 51 completed trials in Central Arkansas Veterans Healthcare System, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Central Arkansas Veterans Healthcare System, 1 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 20 trials that are defined as “Not Applicable".